Titel: Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
Auteur(s): Sjoukje F Oosting
Astrid A M van der Veldt
Rudolf S N Fehrmann
Corine H GeurtsvanKessel
Rob S van Binnendijk
Anne-Marie C Dingemans
Egbert F Smit
T Jeroen N Hiltermann
Gerco den Hartog
Mathilda Jalving
Tatjana T Westphal
Arkajyoti Bhattacharya
Faye de Wilt
Annemarie Boerma
Lisanne van Zijl
Guus F Rimmelzwaan
Pia Kvistborg
Cecile A C M van Els
Nynke Y Rots
Debbie van Baarle
John B A G Haanen
Elisabeth G E de Vries
Tijdschrift: Lancet Oncology
Start- en eindpagina: 1 - 3
Publicatiedatum: 25-04-2022
DOI: https://doi.org/10.1016/S1470-2045(22)00203-0
Titel: COVID-19 vaccination: the VOICE for patients with cancer
Auteur(s): Astrid A. M. van der Veldt, Sjoukje F. Oosting, Anne-Marie C. Dingemans, Rudolf S. N. Fehrmann, Corine GeurtsvanKessel, Mathilde Jalving, Guus F. Rimmelzwaan, Pia Kvistborg, Christian U. Blank, Egbert F. Smit, Valery E. E. P. Lemmens, T. Jeroen N. Hiltermann, Marion P. G. Koopmans, Anke L. W. Huckriede, Nynke Y. Rots, Cecile A. C. M. van Els, Debbie van Baarle, John B. A. G. Haanen & Elisabeth G. E. de Vries
Tijdschrift: Nature Medicine
Start- en eindpagina: 568 - 569
Publicatiedatum: 15-02-2021
DOI: https://doi.org/10.1038/s41591-021-01240-w
Titel: COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety.
Auteur(s): Fendler A, de Vries EGE, GeurtsvanKessel CH, Haanen JB, Wörmann B, Turajlic S, von Lilienfeld-Toal M.
Tijdschrift: Nature Reviews Clinical Oncology
Start- en eindpagina: 1 - 17
Publicatiedatum: 11-03-2022
DOI: https://doi.org/10.1038/s41571-022-00610-8
Titel: mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
Auteur(s): Sjoukje F Oosting, MD
Astrid A M van der Veldt, MD
Corine H GeurtsvanKessel, MD
Rudolf S N Fehrmann, MD
Rob S van Binnendijk, PhD
Prof Anne-Marie C Dingemans, MD
Prof Egbert F Smit, MD
T Jeroen N Hiltermann, MD
Gerco den Hartog, PhD
Mathilda Jalving, MD
Tatjana T Westphal
Arkajyoti Bhattacharya
Marieke van der Heiden, PhD
Prof Guus F Rimmelzwaan, PhD
Pia Kvistborg, PhD
Prof Christian U Blank, MD
Prof Marion P G Koopmans, PhD
Prof Anke L W Huckriede, PhD
Prof Cecile A C M van Els, PhD
Nynke Y Rots, PhD
Prof Debbie van Baarle, PhD
Prof John B A G Haanen, MD
Prof Elisabeth G E de Vries, MD
Tijdschrift: Lancet Oncology
Start- en eindpagina: 1 - 11
Publicatiedatum: 09-11-2021
DOI: 10.1016/S1470-2045(21)00574-X
Titel: Introduction to the meeting: ESMO Webinar series, Protecting Cancer Patients Against COVID-19: New Strains, New Vaccines, One Year From Vaccine Approvals.
Auteur(s): Haanen J
Publicatiedatum: 23-03-2022
Titel: De VOICE studie; een onderzoek naar de werking van het coronavaccin bij patiënten die chemo- of immunotherapie ondergaan
Auteur(s): Haanen J
Publicatiedatum: 24-11-2021
Titel: COVID-19 en oncologie
Auteur(s): de Vries EGE
Publicatiedatum: 29-09-2021
Titel: Understanding and improving vaccine responses in vulnerable groups: the ‘Vaccination against cOvid In CancEr’ VOICE study
Auteur(s): Oosting SF
Publicatiedatum: 09-06-2021
Titel: Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
Auteur(s): Oosting SF
Publicatiedatum: 20-09-2021
Titel: Vaccination against COVID-19 in patients with solid tumors
Auteur(s): Oosting SF
Publicatiedatum: 15-10-2021
Titel: Vaccination against COVID-19 in patients with solid tumors
Auteur(s): Oosting SF
Publicatiedatum: 10-11-2021
Titel: Vaccination against COVID-19 in patients with solid tumors
Auteur(s): Oosting SF
Publicatiedatum: 07-12-2021
Titel: Vaccination against SARS-CoV-2 in patients receiving chemotherapy, immunotherapy, or chemo-immunotherapy for solid tumors
Auteur(s): Oosting SF
Publicatiedatum: 07-12-2021
Titel: Immunogenicity and safety of vaccines against SARS-CoV-2 in patients with solid cancers
Auteur(s): Oosting SF
Publicatiedatum: 16-02-2022